Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Novartis
Covington
McKinsey
Moodys
Merck
Harvard Business School
Accenture
Johnson and Johnson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Calcipotriene - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for calcipotriene and what is the scope of calcipotriene patent protection?

Calcipotriene
is the generic ingredient in three branded drugs marketed by Mayne Pharma, Glenmark Pharms, Tolmar, Leo Pharma As, Glenmark Pharms Inc, Fougera Pharms, G And W Labs Inc, Hi Tech Pharma, Novel Labs Inc, and Leo Pharm, and is included in twelve NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Calcipotriene has twenty-six patent family members in twelve countries.

There are twelve drug master file entries for calcipotriene. Thirteen suppliers are listed for this compound.
Summary for calcipotriene
Pharmacology for calcipotriene
Ingredient-typeVitamin D
Drug ClassVitamin D Analog

US Patents and Regulatory Information for calcipotriene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms CALCIPOTRIENE calcipotriene CREAM;TOPICAL 205772-001 Jun 9, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glenmark Pharms Inc CALCIPOTRIENE calcipotriene OINTMENT;TOPICAL 090633-001 Mar 24, 2010 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mayne Pharma SORILUX calcipotriene AEROSOL, FOAM;TOPICAL 022563-001 Oct 6, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tolmar CALCIPOTRIENE calcipotriene CREAM;TOPICAL 200935-001 May 30, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 078468-001 Mar 24, 2011 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 078305-001 May 6, 2008 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hi Tech Pharma CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 077579-001 Nov 19, 2009 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tolmar CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 077029-001 Nov 20, 2009 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for calcipotriene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996 ➤ Sign Up ➤ Sign Up
Leo Pharma As DOVONEX calcipotriene OINTMENT;TOPICAL 020273-001 Dec 29, 1993 ➤ Sign Up ➤ Sign Up
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Sign Up ➤ Sign Up
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Sign Up ➤ Sign Up
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Sign Up ➤ Sign Up
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996 ➤ Sign Up ➤ Sign Up
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for calcipotriene

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,730,288 Mousse composition ➤ Sign Up
7,029,659 Mousse composition ➤ Sign Up
8,298,515 Vitamin formulation ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for calcipotriene

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fuji
Argus Health
Chinese Patent Office
Covington
Colorcon
Dow
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot